NOTICE OF INTENT TO SOLE SOURCE - NEW MEDICATION DATA SURVEILLANCE PROJECT

NOTICE OF INTENT TO SOLE SOURCE The Centers for Disease Control and Prevention (CDC) intends to award a sole-source firm-fixed price purchase order to The Institute for Biometry and Edpidemiology German Diabetes Center for the estimation and modeling of trends in hypertention incidence in U.S. adults with and without diabetes. This requirement is for (supplies/services) in which the Government intends to solicit and negotiate with only one-source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement. This notice of intent is not a request for competitive quotations; however, all responses received within seven (7) days of the issuance of this notice will be reviewed. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any response should be emailed to the contract specialist at [email protected] by 1:00 p.m. Eastern Standard Time (EST) on July 1, 2020 @ 1:00 p.m.